发明名称 |
Use of carbocycline derivs. - esp. iloprost, cicaprost, eptaloprost, beraprost or ciprostene, for treatment of vitiligo |
摘要 |
The use of carbocycline derivs. (I) and their base salts and cyclodextrin clathrates for the treatment of vitiligo is new. (I) is pref. iloprost, cicaprost, eptaloprost, beraprost or ciprostene. USE/ADVANTAGE - (I) are TNF-synthesis inhibitors and are pref. applied topically in conventional dosage forms contg. 20-40 mcg/g vehicle. Max. tolerated daily dose is 80-160 mcg. (I) are superior to monoclonal antibodies against TNF and have reduced side effects compared with other known treatments such as PUVA therapy. They are vascular protective, produce a long term hyperpigmentation when used topically and are also active when used prophylactically
|
申请公布号 |
DE4124693(A1) |
申请公布日期 |
1993.01.28 |
申请号 |
DE19914124693 |
申请日期 |
1991.07.22 |
申请人 |
SCHERING AG BERLIN UND BERGKAMEN, 1000 BERLIN, DE |
发明人 |
BLITTSTEIN-WILLINGER, EVELINE, DR., 1000 BERLIN, DE |
分类号 |
A61K31/557 |
主分类号 |
A61K31/557 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|